Published in Clin Vaccine Immunol on March 26, 2008
CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci (2010) 1.02
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice. Mucosal Immunol (2012) 0.90
IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women. Malar J (2014) 0.80
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer. Int J Mol Sci (2016) 0.78
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients. Oncoimmunology (2012) 0.77
Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor. Oncoimmunology (2015) 0.75
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med (2001) 5.74
Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods (2006) 2.54
Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology (1989) 1.99
In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells. Proc Natl Acad Sci U S A (1999) 1.87
Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol (2001) 1.84
Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol (1999) 1.67
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res (2004) 1.51
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol (1998) 1.48
Systemic T cell expansion during localized viral infection. Eur J Immunol (1999) 1.37
Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol (1997) 1.29
Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine. Vaccine (2002) 1.25
Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms. Mol Cell Biol (2001) 1.19
Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa. J Immunol (2006) 1.18
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes. J Virol (2003) 1.14
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol (2003) 1.12
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res (2003) 1.12
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nat Rev Cancer (2002) 1.12
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol (2002) 1.09
Intensity of the vaccine-elicited immune response determines tumor clearance. J Immunol (2002) 1.07
MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection. J Immunol (2004) 1.05
Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol (2006) 1.05
Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule. J Immunol (2004) 1.02
Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa. Virology (2004) 0.93
The PY motif of ENaC, mutated in Liddle syndrome, regulates channel internalization, sorting and mobilization from subapical pool. Traffic (2007) 1.49
Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain. Biochem J (2008) 1.36
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection. J Virol (2011) 1.32
Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Clin Vaccine Immunol (2007) 1.23
Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype. Am J Physiol Renal Physiol (2012) 1.14
Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension. J Clin Invest (2013) 1.13
Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines. Vaccine (2008) 1.07
Chapter 17: Second generation HPV vaccines to prevent cervical cancer. Vaccine (2006) 1.04
A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers. Int J Cancer (2011) 0.99
Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1. J Virol (2004) 0.99
Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect Immun (2008) 0.95
Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors. Int J Cancer (2011) 0.95
Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer (2010) 0.94
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev (2014) 0.92
Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Vaccine (2009) 0.89
Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium. Infect Immun (2004) 0.89
Liddle's syndrome caused by a novel missense mutation (P617L) of the epithelial sodium channel beta subunit. J Hypertens (2008) 0.88
Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants. Antiviral Res (2007) 0.86
The importance of mucosal immunity in defense against epithelial cancers. Curr Opin Immunol (2005) 0.83
International collaborative proficiency study of Human Papillomavirus type 16 serology. Vaccine (2011) 0.83
Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates. Int J Public Health (2009) 0.82
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells. Oncoimmunology (2013) 0.78
USP2-45 represses aldosterone mediated responses by decreasing mineralocorticoid receptor availability. Cell Physiol Biochem (2013) 0.78
Mice carrying ubiquitin-specific protease 2 (Usp2) gene inactivation maintain normal sodium balance and blood pressure. Am J Physiol Renal Physiol (2013) 0.77
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients. Oncoimmunology (2012) 0.77
SITC 26th annual meeting--summary. J Transl Med (2012) 0.75